14.11.2022 - – Cash Position of $21.3 Million as of September 30, 2022 – – Hosting Phase 3 REGAL Study Update Webcast Today at 8:30 a.m. ET – NEW YORK, Nov. 14, 2022 (GLOBE NEWSWIRE) - SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or .
On Monday, Aravive Inc. (Nasdaq: ARAV) advanced 4.55% to $0.83 after achieving a significant milestone. It gained 1.78% to complete the last trading session at $0.79. What milestone has ARAV reached? Aravive (ARAV) announced yesterday that its licensee, 3D Medicines Inc., has provided the company wi
Corbus Pharmaceuticals (NASDAQ:CRBP – Get Rating) and Aravive (NASDAQ:ARAV – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings. Profitability This table compares Corbus Pharmaceuticals and Aravive’s net margins, […]
SELLAS Life Sciences Provides Business Update and First Quarter 2022 Highlights forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.